Digital AI is redefining decision-making in biopharma R&D AI has kickstarted a new wave of innovation in biopharma R&D.
Digital Digital tools must be used in pharma manufacturing to keep p... The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.